-
ALIM Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Alimera Sciences (ALIM)
Company Profile
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 14.35 mm | 14.35 mm | 14.35 mm | 14.35 mm | 14.35 mm | 14.35 mm |
Cash burn (monthly) | (no burn) | (no burn) | 2.09 mm | 1.52 mm | 188.67 k | 1.05 mm |
Cash used (since last report) | n/a | n/a | 18.36 mm | 13.30 mm | 1.65 mm | 9.22 mm |
Cash remaining | n/a | n/a | -4.02 mm | 1.04 mm | 12.69 mm | 5.13 mm |
Runway (months of cash) | n/a | n/a | -1.9 | 0.7 | 67.3 | 4.9 |
13F holders | Current |
---|---|
Total holders | 31 |
Opened positions | 19 |
Closed positions | 22 |
Increased positions | 4 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 209.55 bn |
Total shares | 49.71 mm |
Total puts | 18.60 k |
Total calls | 0.00 |
Total put/call ratio | Infinity |
Largest owners | Shares | Value |
---|---|---|
Caligan Partners | 16.84 mm | $93.60 bn |
Velan Capital Investment Management | 13.61 mm | $75.66 bn |
Therapeutics OcuMension | 11.45 mm | $112.21 mm |
Stonepine Capital Management | 3.51 mm | $19.53 bn |
Altium Capital Management | 2.15 mm | $11.95 bn |
Glazer Capital | 551.53 k | $3.07 mm |
MS Morgan Stanley | 515.30 k | $2.87 bn |
STT State Street | 374.53 k | $2.08 bn |
Bridgeway Capital Management | 139.10 k | $773.40 mm |
Deltec Asset Management | 124.17 k | $690.38 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Sep 24 | Adam Morgan | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 4,178,725 | 0.00 | 0 |
16 Sep 24 | Adam Morgan | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 9,429,808 | 0.00 | 0 |
16 Sep 24 | Adam Morgan | Warrants Common Stock | Sale back to company | Dispose D | Yes | No | 2.1 | 800,000 | 1.68 mm | 0 |
16 Sep 24 | Adam Morgan | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.99 | 50,000 | 149.50 k | 0 |
16 Sep 24 | Adam Morgan | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 1.85 | 1,825 | 3.38 k | 0 |
16 Sep 24 | Caligan Partners | Common Stock, par value $0.01 per share ("Common Stock") | Other | Dispose J | Yes | No | 0 | 16,835,154 | 0.00 | 0 |
16 Sep 24 | Caligan Partners | Notional Derivative Agreements (obligation to buy) Common Stock | Other | Dispose J | Yes | No | 0 | 1 | 0.00 | 0 |
16 Sep 24 | Caligan Partners | Warrants Common Stock | Other | Dispose J | Yes | No | 2.1 | 800,000 | 1.68 mm | 0 |
16 Sep 24 | Snisarenko John | Common Stock | Sale back to company | Dispose D | No | No | 0 | 10,000 | 0.00 | 0 |
16 Sep 24 | Snisarenko John | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.865 | 46,150 | 39.92 k | 0 |